This Phase III clinical trial is a randomized, double-blind, placebo-controlled, multicenter clinical trial in China to evaluate the safety and efficacy of ASC40
Combines biocompatibility, heat-resistance, transparency and durability
JPL plans to sell its entire 25.8% equity stake in Sofie for aggregate proceeds of about US$ 139.43 million
The registered capital of the newly founded company is € 50 million
Aarti Drugs has reported total income of Rs. 607.61 crores during the period ended December 31, 2023
Microdosing has emerged as a key trend in the pharmaceutical and nutritional markets
The company has secured two orders for male condoms from CMSS worth Rs. 9.65 crores and Rs. 6.58 crores respectively
The clearance of this audit marks the successful registration of 8 APIs with CADIFA
The congress aims at emphasizing on the most recent trends, advancements in the field of Obstetrics & Gynaecology
The survey data presented in “The State of the Biopharmaceutical Industry 2024” report reveals that N=21 (18%) of industry professionals were convinced that CGT will dominate as the most important trend in pharma next year
Subscribe To Our Newsletter & Stay Updated
